Overview

Treatment of Disseminated High Grade Lymphoma

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
Interest of the use of pegylated liposomal doxorubicin (caélyx)
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
French Innovative Leukemia Organisation
Treatments:
Doxorubicin
Liposomal doxorubicin